GLP-1 Eye Effects Raise Questions - Takeaways - MDSpire

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

  • By

  • Kerri Miller

  • March 24, 2026

  • 2 min

Share

  • 1

    Semaglutide is associated with ischaemic optic neuropathy, with higher reporting odds in males and those using obesity-dose formulations.

  • 2

    Observational studies suggest GLP-1 receptor agonists may reduce risks of nonexudative age-related macular degeneration and noninfectious uveitis.

  • 3

    A 3-year study found a twofold increase in neovascular age-related macular degeneration among diabetes patients using GLP-1 RAs.

  • 4

    Pharmacovigilance data indicate the need for further study on the ocular effects of GLP-1 RAs, especially with increasing usage.

  • 5

    Experts recommend screening for diabetic retinopathy before initiating GLP-1 RAs and reporting adverse events through the yellow card system.

Original Source(s)

GLP-1 Eye Effects Raise Questions

  • by Kerri Miller

  • March 24, 2026

Related Content

Side Effects: Context Is the Diagnosis

This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min
Retinal Features May Reveal Depression

In a UK Biobank cohort, thinner ganglion cell-inner plexiform layer and macular measurements were associated with incident depression over more than a decade of follow-up, while no independent association emerged for anxiety disorders.